100 related articles for article (PubMed ID: 11749121)
1. Low level lead exposure in vitro stimulates the proliferation and expansion of alloantigen-reactive CD4(high) T cells.
McCabe MJ; Singh KP; Reiners JJ
Toxicol Appl Pharmacol; 2001 Dec; 177(3):219-31. PubMed ID: 11749121
[TBL] [Abstract][Full Text] [Related]
2. Lead enhances CD4+ T cell proliferation indirectly by targeting antigen presenting cells and modulating antigen-specific interactions.
Farrer DG; Hueber SM; McCabe MJ
Toxicol Appl Pharmacol; 2005 Sep; 207(2):125-37. PubMed ID: 15885731
[TBL] [Abstract][Full Text] [Related]
3. The phenotype and survival of antigen-stimulated transgenic CD4 T cells in vivo: the influence of persisting antigen.
Yang CP; Sparshott SM; Duffy D; Garside P; Bell EB
Int Immunol; 2006 Apr; 18(4):515-23. PubMed ID: 16481344
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
5. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
6. Long-term exposure to superantigen induces p27Kip1 and Bcl-2 expression in effector memory CD4+ T cells.
Koyanagi M; Fukada K; Uchiyama T; Yagi J; Arimura Y
Cell Immunol; 2007 Aug; 248(2):77-85. PubMed ID: 18001700
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells.
Nikolaeva N; Bemelman FJ; Yong SL; van Lier RA; ten Berge IJ
Transplantation; 2006 Feb; 81(3):445-54. PubMed ID: 16477233
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific CD4+ effector T cells: analysis of factors regulating clonal expansion and cytokine production: clonal expansion and cytokine production by CD4+ effector T cells.
Ohnuki K; Watanabe Y; Takahashi Y; Kobayashi S; Watanabe S; Ogawa S; Kotani M; Kozono H; Tanabe K; Abe R
Biochem Biophys Res Commun; 2009 Mar; 380(4):742-7. PubMed ID: 19338745
[TBL] [Abstract][Full Text] [Related]
10. Visualizing memory phenotype development after in vitro stimulation of CD4(+) T cells.
Lee WT; Pelletier WJ
Cell Immunol; 1998 Aug; 188(1):1-11. PubMed ID: 9743552
[TBL] [Abstract][Full Text] [Related]
11. Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset.
Xystrakis E; Bernard I; Dejean AS; Alsaati T; Druet P; Saoudi A
Eur J Immunol; 2004 Feb; 34(2):408-17. PubMed ID: 14768045
[TBL] [Abstract][Full Text] [Related]
12. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
[TBL] [Abstract][Full Text] [Related]
13. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
[TBL] [Abstract][Full Text] [Related]
14. Induction of acute graft-versus-host disease by T cells that do not respond to in vitro alloantigen stimulation.
New JY; Chan SH; Yap EH; Hu H
Br J Haematol; 2004 Sep; 126(6):828-36. PubMed ID: 15352987
[TBL] [Abstract][Full Text] [Related]
15. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
17. Progressive changes in CD45RB phenotype and lymphokine production by murine CD4+ T cells after alloantigen exposure.
Birkeland ML; Kraus T; Tardelli L; Puré E
Immunology; 1992 Apr; 75(4):632-8. PubMed ID: 1350569
[TBL] [Abstract][Full Text] [Related]
18. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
19. G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice.
Sabzevari H; Propp S; Kono DH; Theofilopoulos AN
Eur J Immunol; 1997 Aug; 27(8):1901-10. PubMed ID: 9295025
[TBL] [Abstract][Full Text] [Related]
20. Induction of CD69 antigen on normal CD4+ and CD8+ lymphocyte subsets and its relationship with the phenotype of responding T-cells.
Rutella S; Rumi C; Lucia MB; Barberi T; Puggioni PL; Lai M; Romano A; Cauda R; Leone G
Cytometry; 1999 Jun; 38(3):95-101. PubMed ID: 10397327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]